Welcome to the
European Biotechnology Network!
The European Biotechnology Network is dedicated to facilitating co-operation between professionals in biotechnology and the life sciences all over Europe.
The non-profit organisation brings research groups, universities, SMEs, large companies and indeed all actors in biotechnology together to build and deliver partnerships.
Read more about our activities here.
Dutch-Danish dermatology deal22.05.2015 Dutch arGEN-X and Danish LEO Pharma are pairing up to develop antibody-based treatments for the chronic inflammation that causes many skin conditions.The Latest Catch is brought to you by European Biotechnology News
Ballerup-based LEO Pharma will get access to one of arGEN-X’ antibodies, which is currently being developed for inflammation-related skin diseases. In return, arGEN-X will receive pre-IND payments of €4.5m, including an upfront payment, as well as milestone payments of up to €100m plus royalties. The allies will co-fund product development costs up to clinical trial application filing.
Breda-based arGEN-X N.V. develops therapeutic antibodies, and usually focuses on the treatment of cancer and severe autoimmune diseases. Danish LEO Pharma A/S, on the other hand, specialises in skin-related therapies, such as treatments for psoriasis and actinic keratosis. “We see huge potential in this new partnership in harnessing the complementary expertise of both companies: arGEN-X’ advanced knowledge and capabilities in therapeutic antibody development and LEO Pharma’s global expertise in bringing products to market that meet the needs of dermatology patients,” said Tim Van Hauwermeiren, Chief Executive Officer of arGEN-X. Added Thorsten Thormann, Senior Vice President, New Product Discovery at LEO Pharma: “Our alliance with arGEN-X is an important step forward as it marks our entry into the area of biotherapeutics for dermatology.”
Our Corporate Members are
European Biotechnology Network AISBL
Rue de la Science 14b
1040 Brussels, Belgium
Tel: +32 27 33 72 37
Join the European Biotechnology Network!
Individual Membership for natural persons is free, while Corporate Membership, for companies, institutions and research groups start from €500 p.a.